| Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project JR Nebeker, R Virmani, CL Bennett, JM Hoffman, MH Samore, J Alvarez, ... Journal of the American College of Cardiology 47 (1), 175-181, 2006 | 831 | 2006 |
| Pure red-cell aplasia and epoetin therapy CL Bennett, S Luminari, AR Nissenson, MS Tallman, SA Klinge, ... New England Journal of Medicine 351 (14), 1403-1408, 2004 | 548 | 2004 |
| Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports AM Evens, BD Jovanovic, YC Su, DW Raisch, D Ganger, SM Belknap, ... Annals of Oncology 22 (5), 1170-1180, 2011 | 400 | 2011 |
| A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia S Nelson, SM Belknap, RW Carlson, D Dale, B DeBoisblanc, S Farkas, ... The Journal of infectious diseases 178 (4), 1075-1080, 1998 | 274 | 1998 |
| Adverse drug events in emergency department patients JW Hafner Jr, SM Belknap, MD Squillante, KA Bucheit Annals of emergency medicine 39 (3), 258-267, 2002 | 250 | 2002 |
| Urinary excretion of cocaine, benzoylecgonine, and ecgonine methyl ester in humans J Ambre, TI Ruo, J Nelson, S Belknap Journal of analytical toxicology 12 (6), 301-306, 1988 | 166 | 1988 |
| The research on adverse drug events and reports (RADAR) project CL Bennett, JR Nebeker, EA Lyons, MH Samore, MD Feldman, JM McKoy, ... Jama 293 (17), 2131-2140, 2005 | 163 | 2005 |
| Acute tolerance to cocaine in humans JJ Ambre, SM Belknap, J Nelson, TI Ruo, SG Shin, AJ Atkinson Jr Clinical Pharmacology & Therapeutics 44 (1), 1-8, 1988 | 162 | 1988 |
| Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non–HIV-infected individuals SM Patel, S Johnson, SM Belknap, J Chan, ES Beverly, C Bennett JAIDS Journal of Acquired Immune Deficiency Syndromes 35 (2), 120-125, 2004 | 154 | 2004 |
| Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the … BJ Edwards, AD Bunta, J Lane, C Odvina, DS Rao, DW Raisch, ... JBJS 95 (4), 297-307, 2013 | 151 | 2013 |
| Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research … CL Bennett, D Cournoyer, KR Carson, J Rossert, S Luminari, AM Evens, ... Blood 106 (10), 3343-3347, 2005 | 139 | 2005 |
| Relation of plasma oxytocin and prolactin concentrations to milk production in mothers of preterm infants: influence of stress RT Chatterton Jr, PD Hill, JC Aldag, KR Hodges, SM Belknap, ... The Journal of Clinical Endocrinology & Metabolism 85 (10), 3661-3668, 2000 | 133 | 2000 |
| Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports … LA Ladewski, SM Belknap, JR Nebeker, O Sartor, EA Lyons, TC Kuzel, ... Journal of clinical oncology 21 (20), 3859-3866, 2003 | 89 | 2003 |
| Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report B Nardone, E Saddleton, AE Laumann, BJ Edwards, DW Raisch, ... Pediatric radiology 44, 173-180, 2014 | 82 | 2014 |
| Amiodarone-associated optic neuropathy: a critical review RS Passman, CL Bennett, JM Purpura, R Kapur, LN Johnson, DW Raisch, ... The American journal of medicine 125 (5), 447-453, 2012 | 81 | 2012 |
| High-alert’medications and patient safety S Belknap Int J Qual Health Care 13 (4), 339, 2001 | 80 | 2001 |
| Effect of genetic variants, especially CYP2C9 and VKORC1, on the pharmacology of warfarin E Fung, NA Patsopoulos, SM Belknap, DJ O'Rourke, JF Robb, ... Seminars in thrombosis and hemostasis 38 (08), 893-904, 2012 | 78 | 2012 |
| Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride T Kiguradze, WH Temps, PR Yarnold, J Cashy, RE Brannigan, B Nardone, ... PeerJ 5, e3020, 2017 | 75 | 2017 |
| Adverse event reporting in clinical trials of finasteride for androgenic alopecia: a meta-analysis SM Belknap, I Aslam, T Kiguradze, WH Temps, PR Yarnold, J Cashy, ... JAMA dermatology 151 (6), 600-606, 2015 | 71 | 2015 |
| Clinical features and correlates of gemcitabine‐associated lung injury: findings from the RADAR project SM Belknap, TM Kuzel, PR Yarnold, N Slimack, EA Lyons, DW Raisch, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2006 | 70 | 2006 |
Paul R Yarnold, Ph.D.CEO, Optimal Data AnalysisVerified email at planetyarnold.com
